StockData
Legend Biotech Corp logo

Legend Biotech Corp (LEGN) stock

LEGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 10, 2026Score 3/30
$16.11+0.12 (+0.75%)

Close on Nov 17, 2026Market cap $2.98BP/E –Yield –

Legend Biotech profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Legend Biotech's profit margin for the twelve months ending Mar 31, 2025 was -30.0%. For fiscal 2024 it was -28.2%, against -181.8% the year before. The highest annual figure on record is -5.7% in fiscal 2018.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-28.2%+153.6
FY2023Dec 31, 2023-181.8%+199.7
FY2022Dec 31, 2022-381.5%+204.9
FY2021Dec 31, 2021-586.4%−231.2
FY2020Dec 31, 2020-355.2%−185.8
FY2019Dec 31, 2019-169.4%−163.7
FY2018Dec 31, 2018-5.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2025Mar 31, 2025-51.8%+11.9
Q4 FY2024Dec 31, 202414.1%+196.4
Q3 FY2024Sep 30, 2024-78.2%−13.4
Q2 FY2024Jun 30, 2024-9.8%+261.8
Q1 FY2024Mar 31, 2024-63.6%+244.9
Q4 FY2023Dec 31, 2023-182.3%+309.4
Q3 FY2023Sep 30, 2023-64.8%+245.7
Q2 FY2023Jun 30, 2023-271.6%–
Q1 FY2023Mar 31, 2023-308.5%–
Q4 FY2022Dec 31, 2022-491.7%–
Q3 FY2022Sep 30, 2022-310.5%–

More Legend Biotech figures

See a number that looks wrong?